MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,875 | -99.7% | 180,840 | +80.7% | 0.00% | 0.0% |
| Q3 2022 | $1,798,000 | +933.3% | 100,094 | +614.9% | 0.00% | – |
| Q2 2022 | $174,000 | -64.8% | 14,001 | -62.3% | 0.00% | – |
| Q1 2022 | $495,000 | +326.7% | 37,172 | +622.2% | 0.00% | – |
| Q3 2021 | $116,000 | +274.2% | 5,147 | +280.4% | 0.00% | – |
| Q2 2021 | $31,000 | -91.9% | 1,353 | -92.7% | 0.00% | – |
| Q1 2021 | $381,000 | -70.3% | 18,536 | -60.1% | 0.00% | -100.0% |
| Q4 2020 | $1,284,000 | +28.4% | 46,500 | -34.7% | 0.00% | 0.0% |
| Q3 2020 | $1,000,000 | -38.9% | 71,200 | -10.3% | 0.00% | 0.0% |
| Q2 2020 | $1,637,000 | +301.2% | 79,400 | +201.9% | 0.00% | – |
| Q4 2019 | $408,000 | +591.5% | 26,300 | +132.4% | 0.00% | – |
| Q3 2019 | $59,000 | -28.0% | 11,317 | +24.6% | 0.00% | – |
| Q2 2019 | $82,000 | -35.4% | 9,083 | -16.5% | 0.00% | – |
| Q2 2017 | $127,000 | +12600.0% | 10,877 | +7506.3% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 143 | -28.5% | 0.00% | – |
| Q4 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |